These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19936577)

  • 1. [Old and new anticoagulants. Antidotes and measures for acute hemorrhaging and urgent interventions].
    Lancé M; Stessel B; Hamulyák K; Marcus MA
    Anaesthesist; 2010 Jan; 59(1):62, 64-8. PubMed ID: 19936577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bleeding complications in patients on anticoagulant therapy.
    Piran S; Schulman S
    Blood; 2019 Jan; 133(5):425-435. PubMed ID: 30559261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversal strategies for non-vitamin K antagonist oral anticoagulants].
    Larsen FU; Hvas AM; Grove EL
    Ugeskr Laeger; 2016 Oct; 178(40):. PubMed ID: 27697119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism.
    Haverkamp D; Hutten BA; Büller HR; Gallus AS; Lensing AW; Prins MH
    J Thromb Haemost; 2003 Jan; 1(1):69-73. PubMed ID: 12871541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.
    Levi M; Eerenberg E; Kamphuisen PW
    J Thromb Haemost; 2011 Sep; 9(9):1705-12. PubMed ID: 21729240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of anticoagulants: an overview of current developments.
    Greinacher A; Thiele T; Selleng K
    Thromb Haemost; 2015 May; 113(5):931-42. PubMed ID: 25832311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding complications of anticoagulant therapy].
    Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
    Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
    Levi MM; Eerenberg E; Löwenberg E; Kamphuisen PW
    Neth J Med; 2010 Feb; 68(2):68-76. PubMed ID: 20167958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulants and their reversal.
    Schulman S; Bijsterveld NR
    Transfus Med Rev; 2007 Jan; 21(1):37-48. PubMed ID: 17174219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antidotes for reversal of old and new oral anticoagulants.
    Suryanarayan D; Schulman S
    Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NOAC: Real-life data and the role of antidotes for the treatment of bleeding].
    Darius H
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):99-104. PubMed ID: 28144725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From heparin to apixaban: anticoagulants cut both ways?].
    Hartung K; Meyer F; Bock F; Isermann B
    Zentralbl Chir; 2014 Feb; 139(1):89-97. PubMed ID: 23460104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal for heparins and new anticoagulant treatments].
    Kortchinsky T; Vigué B; Samama CM
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulants (DOAC) - Management of emergency situations.
    Lindhoff-Last E
    Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants and status of antidotes for the reversal of bleeding risk.
    Ebright J; Mousa SA
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):105-14. PubMed ID: 25115762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
    Maneno JN; Ness GL
    Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antidotes in development for reversal of novel anticoagulants: a review.
    Gomez-Outes A; Suarez-Gea ML; Lecumberri R; Terleira-Fernandez AI; Vargas-Castrillon E
    Recent Pat Cardiovasc Drug Discov; 2014; 9(1):2-10. PubMed ID: 25494843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding Complications and Management on anticoagulant therapy.
    Schulman S
    Semin Thromb Hemost; 2017 Nov; 43(8):886-892. PubMed ID: 28364736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of vitamin K antagonists prior to urgent surgery.
    Grobler C; Callum J; McCluskey SA
    Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.